Algeria, India Chart Strategic Pharmaceutical Partnership Oriented Toward Regional, African Markets

Algeria, India Chart Strategic Pharmaceutical Partnership Oriented Toward Regional, African Markets

✍️ 𝓑𝔂: 𝓓𝓻. 𝓗𝓪𝓷𝓪 𝓢𝓪𝓪𝓭𝓪

𝓐𝓵𝓰𝓲𝓮𝓻𝓼 – 𝓙𝓪𝓷𝓾𝓪𝓻𝔂 𝟐𝟎𝟐𝟔 – The pharmaceutical sector offers vast and promising opportunities for Algerian and Indian companies to materialize joint investment projects and build a sustainable, mutually beneficial partnership, particularly with a view toward regional and African markets. This consensus emerged during the India–Algeria Pharmaceutical Business Forum held in Algiers, which brought together senior officials, diplomats, and leading operators from both countries.

Speaking on the occasion, Ms. Sihem Nafaa, Director of Promotion and Support of Economic Exchanges at the Ministry of Foreign Affairs, the National Community Abroad and African Affairs, emphasized that the pharmaceutical industry, as a strategic sector, harbors exceptional potential for fruitful partnerships between Algeria and India. She underlined the strong complementarity between the assets and capabilities of the two countries, stressing that this synergy constitutes a solid foundation for long-term cooperation.

Ms. Nafaa recalled that the pharmaceutical industry has been elevated to the rank of a national strategic priority in Algeria, with the establishment of a dedicated ministry since 2020. Thanks to the combined efforts of public authorities and private operators, Algeria has succeeded in covering more than 80% of its national pharmaceutical needs through locally manufactured medicines. “Algeria has today become an indisputable pharmaceutical hub in Africa,” she affirmed, noting that the country hosts more than 240 operational pharmaceutical factories out of the 640 existing across the continent, in addition to numerous projects currently under development.

Within this framework, Algeria aspires to establish a solid partnership with India in the manufacturing of vitamins, dietary supplements, and generic medicines. Ms. Nafaa highlighted India’s internationally recognized expertise, which could enable Indian companies to gain sustainable access to African and Mediterranean markets through Algeria. She pointed out that Algeria’s strategic geographic position, coupled with its modern infrastructure, offers a favorable platform for regional expansion.

For his part, Mr. Younes Bouarara, Advisor to the Minister of Pharmaceutical Industry, stressed that the sector represents “a major opportunity for a partnership based on technology transfer and local development.” He reaffirmed the ministry’s full readiness to accompany and support Indian companies seeking to invest and develop projects in Algeria. According to him, the Forum constitutes a privileged platform allowing Algerian and Indian enterprises to identify concrete projects and lay the foundations for a durable partnership. He further reiterated Algeria’s openness to value-creating investments and its ambition to position itself as a regional hub for pharmaceutical production and export, considering India a strategic partner in this endeavor.

In turn, the Ambassador of India to Algeria, Dr. Swati Vijay Kulkarni, affirmed that Algeria is a key partner for India and a genuine gateway to both Europe and Africa. She noted that the Indian delegation participating in the Forum comprised nearly 100 operators representing more than 65 pharmaceutical companies, all expressing strong interest in investment opportunities. “This visit reflects our friendship and our shared determination to strengthen a mutually beneficial partnership in this strategic sector,” she stated, adding that India—widely recognized as the pharmacy of the world and one of the fastest-growing economies—considers Algeria a valuable and reliable partner.

The Ambassador further emphasized that the Forum marked the first trade delegation hosted by the Indian Embassy in 2026, describing it as a foundational milestone expected to set the tone for India–Algeria economic and industrial cooperation in the years ahead.

In addition, the Indian envoy underlined that the presence of such a large, sector-focused delegation—entirely dedicated to pharmaceuticals—constituted a source of pride, reflecting the strategic depth and seriousness with which both sides approach cooperation in this vital industry.

Highlighting India’s global standing, Dr. Kulkarni recalled that India today is widely regarded as the “pharmacy of the world,” supported by a pharmaceutical industry valued at approximately USD 55 billion, with internationally recognized excellence in generic medicines and vaccine production. In parallel, she praised Algeria’s ambitious trajectory, noting that the country is steadily positioning itself as the “pharmacy of Africa,” with nearly 250 pharmaceutical production units out of the continent’s 640, and a national policy that has enabled local production to cover more than 80% of domestic medication needs—an achievement she described as remarkable.

Turning to concrete economic indicators, the Ambassador stressed that pharmaceutical products represent one of India’s key exports to Algeria, revealing that bilateral pharmaceutical trade reached USD 80 million in 2024–2025, while Indian pharmaceutical investments in Algeria exceeded USD 15 million during the same period. She expressed confidence that the current Forum would act as a catalyst, generating up to USD 100 million in new business opportunities within this strategic sector.

She also welcomed the growing participation of Indian pharmaceutical companies in Algeria’s flagship industry events, noting that 64 Indian companies took part in the Maghreb Pharma exhibition in Algiers last year, a sign of sustained and expanding industrial engagement. This dynamic, she observed, demonstrates the increasing alignment between Algerian industrial ambitions and Indian pharmaceutical expertise.

Addressing future cooperation mechanisms, Dr. Kulkarni highlighted two flagship projects currently under development, including ongoing collaboration between Indian companies and the SAIDAL Group at its Bioequivalence Center, as well as a memorandum of understanding on cooperation in the medical devices sector, which is ready for signature. She explained that this MoU would facilitate the exchange of best practices, capacity-building initiatives, and a deeper mutual understanding of regulatory frameworks, thereby accelerating project implementation and industrial integration.

Finally, the Ambassador called for intensified engagement through reciprocal delegation exchanges and participation in sector-specific trade fairs, encouraging Algerian pharmaceutical companies to take part in “Sanjeevani,” a major PHARMEXCIL-organized pharmaceutical event scheduled for 26–27 March 2026 in Chennai. She also advocated for the recognition of the Indian Pharmacopoeia by Algerian authorities, noting that it is the third-largest pharmacopoeia globally, recognized by 17 countries, and that its adoption would significantly streamline and accelerate the importation of APIs and high-quality pharmaceutical products, reinforcing a truly win–win partnership between the two nations.

Mr. Raja Bhanu, Director General of Pharmexcil (Pharmaceuticals Export Promotion Council of India), expressed the strong interest of Indian companies in advanced forms of cooperation, including contract manufacturing in Algeria, joint ventures, and technology transfer, reflecting India’s readiness to engage in high-value, long-term industrial partnerships.

The Forum brought together representatives of Algerian pharmaceutical companies, senior officials from several ministries, as well as representatives of the Algerian Investment Promotion Agency (AAPI), the National Agency for Pharmaceutical Products (ANPP), and the Algerian Chamber of Commerce and Industry (CACI). On this occasion, the Chief Executive Officer of the Saidal Group, Ms. Benygzer née Ouaret, was honored by the Ambassador of India, Dr. Swati Vijay Kulkarni, in recognition of Saidal’s pivotal role in strengthening bilateral relations.

The Forum was also marked by B2B meetings between Algerian and Indian pharmaceutical companies, during which Saidal executives engaged in discussions aimed at establishing concrete and promising collaborations. For Saidal, this event represents a genuine opportunity to structure and deepen industrial cooperation with leading Indian partners, with the objective of developing sustainable partnerships based on know-how transfer, technological expertise sharing, and the enhancement of local competencies, thereby contributing to the development of national pharmaceutical production.

A Closer Look at India’s Expanding Pharmaceutical Might on the Global Stage

India’s pharmaceutical sector, driven by a robust scientific and technological base, stands as a global powerhouse. It is the world’s largest vaccine producer, accounting for approximately 60% of global vaccine production and supplying over 150 countries. The sector encompasses major segments such as generic drugs, over-the-counter medicines, bulk drugs, vaccines, contract research and manufacturing, biosimilars, and biologics. In fiscal year 2024–2025, India’s pharmaceutical exports reached USD 30.4 billion, with imports amounting to USD 8.9 billion, generating a positive trade balance of USD 21.5 billion. Exports span more than 200 countries, with North America, Europe, Latin America, and Africa among the top destinations.

India manufactures over 500 active pharmaceutical ingredients and produces more than 60,000 generic brands across 60 therapeutic categories. With nine of the world’s top 25 generic manufacturers being Indian, the country supplies 20% of the global demand for generic medicines, exporting nearly half of its finished generic dosage forms annually. India is also a global leader in vaccines, having supplied 301 million COVID-19 vaccine doses to 101 countries by mid-2023, and remains at the forefront in BCG, DPT, and measles vaccines.

Furthermore, India is making significant advances in biosimilars, with over 200 products in the development pipeline. Regulatory reforms, including the 2019 New Drug and Clinical Trial Rules, have streamlined approval timelines, while the country’s demographic diversity and strong infrastructure have positioned it as the world’s third most preferred destination for clinical trials, with more than 94,000 trials registered by 2025.

Against this backdrop, the India–Algeria Pharmaceutical Business Forum emerges as a decisive milestone, opening new horizons for a strategic, forward-looking partnership that leverages Algeria’s regional positioning and India’s global pharmaceutical leadership to serve African, Mediterranean, and international markets.

— 𝐄𝐍𝐃 —

📡🌍 | 𝓐𝓫𝓸𝓾𝓽 𝓓𝔃𝓪𝓲𝓻 𝓣𝓾𝓫𝓮 𝓜𝓮𝓭𝓲𝓪 𝓖𝓻𝓸𝓾𝓹 | 🌍📡
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
📰 𝓓𝔃𝓪𝓲𝓻 𝓣𝓾𝓫𝓮 𝓲𝓼 𝓪 𝓽𝓻𝓪𝓲𝓵𝓫𝓵𝓪𝔃𝓮𝓻 𝓲𝓷 𝓐𝓵𝓰𝓮𝓻𝓲𝓪𝓷 𝓭𝓲𝓰𝓲𝓽𝓪𝓵 𝓳𝓸𝓾𝓻𝓷𝓪𝓵𝓲𝓼𝓶, 𝓭𝓮𝓵𝓲𝓿𝓮𝓻𝓲𝓷𝓰 𝓱𝓲𝓰𝓱-𝓺𝓾𝓪𝓵𝓲𝓽𝔂 𝓬𝓸𝓷𝓽𝓮𝓷𝓽 𝓲𝓷 𝓐𝓻𝓪𝓫𝓲𝓬, 𝓕𝓻𝓮𝓷𝓬𝓱, 𝓪𝓷𝓭 𝓔𝓷𝓰𝓵𝓲𝓼𝓱. 𝓦𝓲𝓽𝓱 𝓶𝓸𝓻𝓮 𝓽𝓱𝓪𝓷 📈 500,000 𝓭𝓪𝓲𝓵𝔂 𝓬𝓵𝓲𝓬𝓴𝓼, 𝓲𝓽 𝓻𝓪𝓷𝓴𝓼 𝓪𝓶𝓸𝓷𝓰 𝓽𝓱𝓮 𝓶𝓸𝓼𝓽 𝓲𝓷𝓯𝓵𝓾𝓮𝓷𝓽𝓲𝓪𝓵 𝓶𝓮𝓭𝓲𝓪 𝓹𝓵𝓪𝓽𝓯𝓸𝓻𝓶𝓼 𝓲𝓷 𝓽𝓱𝓮 𝓬𝓸𝓾𝓷𝓽𝓻𝔂.

🏆 𝓐𝔀𝓪𝓻𝓭𝓮𝓭 𝓽𝓱𝓮 𝓟𝓻𝓮𝓼𝓲𝓭𝓮𝓷𝓽 𝓸𝓯 𝓽𝓱𝓮 𝓡𝓮𝓹𝓾𝓫𝓵𝓲𝓬’𝓼 𝓟𝓻𝓲𝔃𝓮 𝓯𝓸𝓻 𝓟𝓻𝓸𝓯𝓮𝓼𝓼𝓲𝓸𝓷𝓪𝓵 𝓙𝓸𝓾𝓻𝓷𝓪𝓵𝓲𝓼𝓽 𝓲𝓷 𝓽𝓱𝓮 𝓔𝓵𝓮𝓬𝓽𝓻𝓸𝓷𝓲𝓬 𝓟𝓻𝓮𝓼𝓼 𝓬𝓪𝓽𝓮𝓰𝓸𝓻𝔂 (🗓 𝓞𝓬𝓽𝓸𝓫𝓮𝓻 22, 2022), 𝓓𝔃𝓪𝓲𝓻 𝓣𝓾𝓫𝓮 𝓲𝓼 𝔀𝓲𝓭𝓮𝓵𝔂 𝓻𝓮𝓬𝓸𝓰𝓷𝓲𝔃𝓮𝓭 𝓯𝓸𝓻 𝓲𝓽𝓼 𝓮𝓭𝓲𝓽𝓸𝓻𝓲𝓪𝓵 𝓮𝔁𝓬𝓮𝓵𝓵𝓮𝓷𝓬𝓮 𝓪𝓷𝓭 𝓲𝓷𝓽𝓮𝓰𝓻𝓲𝓽𝔂.

📱 𝓜𝓪𝓼𝓼𝓲𝓿𝓮 𝓓𝓲𝓰𝓲𝓽𝓪𝓵 𝓡𝓮𝓪𝓬𝓱:
🔴 600,000+ 𝓨𝓸𝓾𝓣𝓾𝓫𝓮 𝓼𝓾𝓫𝓼𝓬𝓻𝓲𝓫𝓮𝓻𝓼
🔵 6 𝓶𝓲𝓵𝓵𝓲𝓸𝓷+ 𝓯𝓸𝓵𝓵𝓸𝔀𝓮𝓻𝓼 𝓪𝓬𝓻𝓸𝓼𝓼 𝓕𝓪𝓬𝓮𝓫𝓸𝓸𝓴 𝓹𝓪𝓰𝓮𝓼
📸 70,000+ 𝓘𝓷𝓼𝓽𝓪𝓰𝓻𝓪𝓶 𝓯𝓸𝓵𝓵𝓸𝔀𝓮𝓻𝓼

🎥 𝓞𝓹𝓮𝓻𝓪𝓽𝓲𝓷𝓰 𝓯𝓻𝓸𝓶 𝓼𝓽𝓪𝓽𝓮-𝓸𝓯-𝓽𝓱𝓮-𝓪𝓻𝓽 𝓼𝓽𝓾𝓭𝓲𝓸𝓼, 𝓓𝔃𝓪𝓲𝓻 𝓣𝓾𝓫𝓮 𝓫𝓻𝓸𝓪𝓭𝓬𝓪𝓼𝓽𝓼 𝓻𝓲𝓬𝓱 𝓪𝓷𝓭 𝓭𝓲𝓿𝓮𝓻𝓼𝓮 𝓹𝓻𝓸𝓰𝓻𝓪𝓶𝓶𝓲𝓷𝓰, 𝓲𝓷𝓬𝓵𝓾𝓭𝓲𝓷𝓰:
🗞 𝓝𝓮𝔀𝓼 | ⚽ 𝓢𝓹𝓸𝓻𝓽𝓼 | 🎭 𝓔𝓷𝓽𝓮𝓻𝓽𝓪𝓲𝓷𝓶𝓮𝓷𝓽 | 🕌 𝓡𝓮𝓵𝓲𝓰𝓲𝓸𝓷 | 🎨 𝓒𝓾𝓵𝓽𝓾𝓻𝓮

🗣️ 𝓕𝓮𝓪𝓽𝓾𝓻𝓲𝓷𝓰 𝓲𝓷𝓽𝓮𝓻𝓪𝓬𝓽𝓲𝓿𝓮 𝓽𝓪𝓵𝓴 𝓼𝓱𝓸𝔀𝓼 𝓪𝓷𝓭 𝓮𝔁𝓬𝓵𝓾𝓼𝓲𝓿𝓮 𝓲𝓷𝓽𝓮𝓻𝓿𝓲𝓮𝔀𝓼 𝔀𝓲𝓽𝓱 𝓹𝓻𝓸𝓶𝓲𝓷𝓮𝓷𝓽 𝓯𝓲𝓰𝓾𝓻𝓮𝓼 𝓯𝓻𝓸𝓶 𝓹𝓸𝓵𝓲𝓽𝓲𝓬𝓼, 𝓫𝓾𝓼𝓲𝓷𝓮𝓼𝓼, 𝓪𝓻𝓽𝓼, 𝓪𝓷𝓭 𝓶𝓸𝓻𝓮, 𝓓𝔃𝓪𝓲𝓻 𝓣𝓾𝓫𝓮 𝓼𝓮𝓻𝓿𝓮𝓼 𝓪𝓼 𝓪 𝓴𝓮𝔂 𝓹𝓵𝓪𝓽𝓯𝓸𝓻𝓶 𝓯𝓸𝓻 𝓹𝓾𝓫𝓵𝓲𝓬 𝓭𝓲𝓼𝓬𝓸𝓾𝓻𝓼𝓮 𝓪𝓷𝓭 𝓬𝓲𝓿𝓲𝓬 𝓮𝓷𝓰𝓪𝓰𝓮𝓶𝓮𝓷𝓽.

📰 𝓘𝓽𝓼 𝓹𝓻𝓲𝓷𝓽 𝓼𝓹𝓸𝓻𝓽𝓼 𝓭𝓪𝓲𝓵𝔂, “𝓓𝔃𝓪𝓲𝓻 𝓢𝓹𝓸𝓻𝓽,” 𝓮𝓷𝓳𝓸𝔂𝓼 𝓸𝓿𝓮𝓻 50,000 𝓭𝓪𝓲𝓵𝔂 𝓭𝓸𝔀𝓷𝓵𝓸𝓪𝓭𝓼 𝓿𝓲𝓪 𝓽𝓱𝓮 𝓸𝓯𝓯𝓲𝓬𝓲𝓪𝓵 𝔀𝓮𝓫𝓼𝓲𝓽𝓮—𝓯𝓾𝓻𝓽𝓱𝓮𝓻 𝓬𝓮𝓶𝓮𝓷𝓽𝓲𝓷𝓰 𝓽𝓱𝓮 𝓹𝓵𝓪𝓽𝓯𝓸𝓻𝓶’𝓼 𝓶𝓾𝓵𝓽𝓲𝓶𝓮𝓭𝓲𝓪 𝓵𝓮𝓪𝓭𝓮𝓻𝓼𝓱𝓲𝓹.

🎖️ 𝓗𝓸𝓷𝓸𝓻𝓮𝓭 𝔀𝓲𝓽𝓱 𝓽𝓱𝓮 𝓜𝓮𝓭𝓲𝓪 𝓛𝓮𝓪𝓭𝓮𝓻𝓼𝓱𝓲𝓹 𝓐𝔀𝓪𝓻𝓭 𝓫𝔂 𝓽𝓱𝓮 𝓯𝓸𝓻𝓶𝓮𝓻 𝓜𝓲𝓷𝓲𝓼𝓽𝓮𝓻 𝓸𝓯 𝓒𝓸𝓶𝓶𝓾𝓷𝓲𝓬𝓪𝓽𝓲𝓸𝓷, 𝓜𝓸𝓱𝓪𝓶𝓮𝓭 𝓛𝓪â𝓰𝓪𝓫, 𝓪𝓷𝓭 𝓬𝓮𝓵𝓮𝓫𝓻𝓪𝓽𝓮𝓭 𝓪𝓽 𝓽𝓱𝓮 𝓗𝓲𝓵𝓪𝓵𝓼 𝓸𝓯 𝓽𝓱𝓮 𝓣𝓮𝓵𝓮𝓿𝓲𝓼𝓲𝓸𝓷 𝓪𝔀𝓪𝓻𝓭𝓼, 𝓓𝔃𝓪𝓲𝓻 𝓣𝓾𝓫𝓮 𝓬𝓸𝓷𝓽𝓲𝓷𝓾𝓮𝓼 𝓽𝓸 𝓵𝓮𝓪𝓭 𝔀𝓲𝓽𝓱 𝓲𝓷𝓷𝓸𝓿𝓪𝓽𝓲𝓸𝓷, 𝓲𝓷𝓯𝓵𝓾𝓮𝓷𝓬𝓮, 𝓪𝓷𝓭 𝓲𝓶𝓹𝓪𝓬𝓽.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
🌐 𝓢𝓽𝓪𝔂 𝓒𝓸𝓷𝓷𝓮𝓬𝓽𝓮𝓭:
🔗 𝓦𝓮𝓫𝓼𝓲𝓽𝓮: www.dzair-tube.dz
🔗 𝓔𝓷𝓰𝓵𝓲𝓼𝓱: www.dzair-tube.dz/en
📲 𝓕𝓸𝓵𝓵𝓸𝔀 𝓾𝓼 𝓸𝓷 𝓕𝓪𝓬𝓮𝓫𝓸𝓸𝓴 | 𝓘𝓷𝓼𝓽𝓪𝓰𝓻𝓪𝓶 | 𝓨𝓸𝓾𝓣𝓾𝓫𝓮
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━